Table 3—

Coronary artery diameters (mm) during the procedure

BaselineCPTIsosorbide dinitrate
Control subjects (n = 56)3.62 ± 0.424.24 ± 0.48*4.58 ± 0.45*
Diabetic patients (n = 72)3.51 ± 0.453.00 ± 0.37*4.38 ± 0.68*
Diabetic patients with no change (group 1, n = 19)3.52 ± 0.413.64 ± 0.424.41 ± 0.57*
Diabetic patients with constriction (group 2, n = 53)3.47 ± 0.462.80 ± 0.36*4.29 ± 0.73*
  • Data are means ± SD.

  • *

    * P < 0.001 vs. baseline.